NO20093536L - Kombinasjonsterapi ved kreftbehandling som omfatter vinflunin og trastuzumab - Google Patents
Kombinasjonsterapi ved kreftbehandling som omfatter vinflunin og trastuzumabInfo
- Publication number
- NO20093536L NO20093536L NO20093536A NO20093536A NO20093536L NO 20093536 L NO20093536 L NO 20093536L NO 20093536 A NO20093536 A NO 20093536A NO 20093536 A NO20093536 A NO 20093536A NO 20093536 L NO20093536 L NO 20093536L
- Authority
- NO
- Norway
- Prior art keywords
- vinflunine
- trastuzumab
- cancer therapy
- therapy including
- combination cancer
- Prior art date
Links
- 229960000575 trastuzumab Drugs 0.000 title abstract 2
- NMDYYWFGPIMTKO-HBVLKOHWSA-N vinflunine Chemical compound C([C@@](C1=C(C2=CC=CC=C2N1)C1)(C2=C(OC)C=C3N(C)[C@@H]4[C@@]5(C3=C2)CCN2CC=C[C@]([C@@H]52)([C@H]([C@]4(O)C(=O)OC)OC(C)=O)CC)C(=O)OC)[C@H]2C[C@@H](C(C)(F)F)CN1C2 NMDYYWFGPIMTKO-HBVLKOHWSA-N 0.000 title abstract 2
- 229960000922 vinflunine Drugs 0.000 title abstract 2
- 238000011275 oncology therapy Methods 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07290679A EP1997534A1 (en) | 2007-05-31 | 2007-05-31 | Cancer treatment combination therapy comprising vinflunine and trastuzumab |
| PCT/EP2008/056620 WO2008145697A1 (en) | 2007-05-31 | 2008-05-29 | Cancer treatment combination therapy comprising vinflunine and trastuzumab |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20093536L true NO20093536L (no) | 2009-12-16 |
Family
ID=38353425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20093536A NO20093536L (no) | 2007-05-31 | 2009-12-16 | Kombinasjonsterapi ved kreftbehandling som omfatter vinflunin og trastuzumab |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20100196363A1 (enExample) |
| EP (2) | EP1997534A1 (enExample) |
| JP (1) | JP2010528091A (enExample) |
| KR (1) | KR20100017752A (enExample) |
| CN (1) | CN101687104A (enExample) |
| AR (1) | AR066778A1 (enExample) |
| AU (1) | AU2008257555A1 (enExample) |
| BR (1) | BRPI0812280A2 (enExample) |
| CA (1) | CA2689664A1 (enExample) |
| CL (1) | CL2008001589A1 (enExample) |
| IL (1) | IL202393A0 (enExample) |
| MX (1) | MX2009012874A (enExample) |
| NO (1) | NO20093536L (enExample) |
| RU (1) | RU2009146882A (enExample) |
| TN (1) | TN2009000490A1 (enExample) |
| TW (1) | TW200908976A (enExample) |
| WO (1) | WO2008145697A1 (enExample) |
| ZA (1) | ZA200908247B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| TWI472339B (zh) | 2008-01-30 | 2015-02-11 | Genentech Inc | 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物 |
| BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
| HUE044352T2 (hu) | 2011-10-14 | 2019-10-28 | Hoffmann La Roche | Pertuzumab, Trastuzumab, Docetaxel és Carboplatin korai stádiumú mellrák kezelésére |
| MY173295A (en) | 2013-04-16 | 2020-01-14 | Genentech Inc | Pertuzumab variants and evaluation thereof |
| WO2018007554A1 (en) * | 2016-07-06 | 2018-01-11 | Pierre Fabre Medicament | Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination |
| DK3570884T3 (da) | 2017-01-17 | 2020-11-30 | Genentech Inc | Subkutane HER2-antistofformuleringer |
| HUE064898T2 (hu) | 2017-03-02 | 2024-04-28 | Genentech Inc | HER2-pozitív emlõrák adjuváns kezelése |
| JP2023532122A (ja) | 2020-06-29 | 2023-07-26 | ジェネンテック， インコーポレイテッド | ペルツズマブにトラスツズマブを加えた固定用量配合剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2707988B1 (fr) * | 1993-07-21 | 1995-10-13 | Pf Medicament | Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant. |
| FR2863891B1 (fr) * | 2003-12-23 | 2006-03-24 | Pf Medicament | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
-
2007
- 2007-05-31 EP EP07290679A patent/EP1997534A1/en not_active Ceased
-
2008
- 2008-05-05 US US12/602,127 patent/US20100196363A1/en not_active Abandoned
- 2008-05-12 TW TW097117418A patent/TW200908976A/zh unknown
- 2008-05-29 KR KR1020097025793A patent/KR20100017752A/ko not_active Withdrawn
- 2008-05-29 BR BRPI0812280-6A2A patent/BRPI0812280A2/pt not_active IP Right Cessation
- 2008-05-29 CN CN200880017406A patent/CN101687104A/zh active Pending
- 2008-05-29 WO PCT/EP2008/056620 patent/WO2008145697A1/en not_active Ceased
- 2008-05-29 JP JP2010509824A patent/JP2010528091A/ja not_active Withdrawn
- 2008-05-29 CA CA2689664A patent/CA2689664A1/en not_active Abandoned
- 2008-05-29 EP EP08760211A patent/EP2164573A1/en not_active Withdrawn
- 2008-05-29 MX MX2009012874A patent/MX2009012874A/es not_active Application Discontinuation
- 2008-05-29 AU AU2008257555A patent/AU2008257555A1/en not_active Abandoned
- 2008-05-29 RU RU2009146882/15A patent/RU2009146882A/ru not_active Application Discontinuation
- 2008-05-30 CL CL2008001589A patent/CL2008001589A1/es unknown
- 2008-05-30 AR ARP080102281A patent/AR066778A1/es not_active Application Discontinuation
-
2009
- 2009-11-23 ZA ZA200908247A patent/ZA200908247B/xx unknown
- 2009-11-23 TN TNP2009000490A patent/TN2009000490A1/fr unknown
- 2009-11-29 IL IL202393A patent/IL202393A0/en unknown
- 2009-12-16 NO NO20093536A patent/NO20093536L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2689664A1 (en) | 2008-12-04 |
| TN2009000490A1 (en) | 2011-03-31 |
| MX2009012874A (es) | 2010-03-31 |
| KR20100017752A (ko) | 2010-02-16 |
| JP2010528091A (ja) | 2010-08-19 |
| AR066778A1 (es) | 2009-09-09 |
| IL202393A0 (en) | 2010-06-30 |
| TW200908976A (en) | 2009-03-01 |
| BRPI0812280A2 (pt) | 2014-11-18 |
| WO2008145697A1 (en) | 2008-12-04 |
| CL2008001589A1 (es) | 2009-03-06 |
| US20100196363A1 (en) | 2010-08-05 |
| EP2164573A1 (en) | 2010-03-24 |
| EP1997534A1 (en) | 2008-12-03 |
| AU2008257555A1 (en) | 2008-12-04 |
| CN101687104A (zh) | 2010-03-31 |
| RU2009146882A (ru) | 2011-07-10 |
| ZA200908247B (en) | 2010-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201000895A1 (ru) | Композиции и способы для лечения лизосомных болезней | |
| NO20091661L (no) | Anvendelse av pegylert IL-10 for a behandle kreft | |
| NO20092637L (no) | Fremgangsmater for behandling | |
| NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
| EA201201400A1 (ru) | Композиции и способы лечения аутоиммунных и других заболеваний | |
| EA201170521A1 (ru) | Новые соединения | |
| MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
| NO2017019I2 (no) | Enzalutamid eller et farmasøytisk akseptabelt salt derav | |
| EA200900819A1 (ru) | Хиназолины для ингибирования pdk1 | |
| BRPI0821779A2 (pt) | tratamento terapêutico de câncer | |
| CY2016015I2 (el) | Αζετιδινες ως αναστολεις μεκ για τη θεραπευτικη αγωγη πολλαπλασιαστικων ασθενειων | |
| EA201170834A1 (ru) | Соединения, пригодные для ингибирования chk1 | |
| EA200700851A1 (ru) | Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения | |
| EA201791669A3 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
| MX2009006706A (es) | Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos. | |
| CY2014006I1 (el) | Μεθοδοι θεραπευτικης αγωγης χρησιμοποιωντας γλυκοπεγκυλιωμενο g-csf | |
| HRP20150449T1 (xx) | Metode lijeäśenja multiplog mijeloma primjenom kombiniranih terapija temeljenih na anti-cs1 antitijelima | |
| EA201370208A1 (ru) | Формы рифаксимина и их применение | |
| EA201001865A1 (ru) | Противовоспалительные агенты | |
| TN2009000490A1 (en) | Cancer treatment combination therapy comprising vinflunine and trastuzumab | |
| ATE532789T1 (de) | Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren | |
| MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
| MX2012010212A (es) | Terapias inhibidoras de autofagia basadas en tioxantona para tratar el cancer. | |
| EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
| EA201390499A1 (ru) | Соединения, подходящие для ингибирования снк1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |